Authors: FREEDMAN BI WUERTH JP CARTWRIGHT K BAIN RP MOORADIAN AD SPINOWITZ BS

Citation: Bi. Freedman et al., DESIGN AND BASE-LINE CHARACTERISTICS FOR THE AMINOGUANIDINE CLINICAL-TRIAL IN OVERT TYPE-II DIABETIC NEPHROPATHY (ACTION-II), Diabetes, 47, 1998, pp. 1431-1431

Authors: MELLINGHOFF AC REININGER AJ WUERTH JP FOUNDS HW LANDGRAF R HEPP KD

Citation: Ac. Mellinghoff et al., FORMATION OF PLASMA ADVANCED GLYCOSYLATION END-PRODUCTS (AGES) HAS NOINFLUENCE ON PLASMA VISCOSITY, Diabetic medicine, 14(10), 1997, pp. 832-836

Authors: WUERTH JP BAIN R MECCA T PARK G CARTWRIGHT K

Citation: Jp. Wuerth et al., BASE-LINE DATA FROM THE PIMAGEDINE ACTION TRIALS, Diabetologia, 40, 1997, pp. 2154-2154

Authors: WUERTH JP BAIN R CARTWRIGHT K

Citation: Jp. Wuerth et al., BASE-LINE DATA FROM THE PIMAGEDINE ACTION TRIALS, Diabetes, 46, 1997, pp. 1180-1180

Authors: HAO EH MENKE JB SMITH AM JONES C GEFFNER ME HERSHMAN JM WUERTH JP SAMUELS HH WAYS DK USALA SJ

Citation: Eh. Hao et al., DIVERGENT DIMERIZATION PROPERTIES OF MUTANT BETA-1 THYROID-HORMONE RECEPTORS ARE ASSOCIATED WITH DIFFERENT DOMINANT-NEGATIVE ACTIVITIES, Molecular endocrinology, 8(7), 1994, pp. 841-851